Company & Sponsor Intelligence
University of Zurich
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials14
Recruiting3
Completed5
Countries1
Therapeutic footprint
alzheimersautismepilepsyhuntingtonsmultiple_sclerosisout_of_scopeparkinsonsstrokesubstance_use
Indexed studies
NCT02744924Intervention to Increase Physical Activity in Older Adults Using Citizen-science and Modern Technology
out_of_scope · SwitzerlandNA
out_of_scope · SwitzerlandNA
NCT02302911Swiss Early Intervention Project in Autism: An Evaluation of Early Intervention Outcome
autism · SwitzerlandUNKNOWN
autism · SwitzerlandUNKNOWN
NCT01879267Exercise Effects in Huntington's Disease
huntingtons · SwitzerlandNA
huntingtons · SwitzerlandNA
NCT02980419Effects of Prolonged Roll-tilt in Healthy Human Subjects
out_of_scope · SwitzerlandNA
out_of_scope · SwitzerlandNA
NCT07534319Investigation of Brain Blood Flow Changes in Acute Ischemic Stroke Patients After Successful Endovascular Thrombectomy
stroke · SwitzerlandRECRUITING
stroke · SwitzerlandRECRUITING
NCT01875146Effects of High-intensity Interval Training in Combination With Side-alternating Whole-body Vibration
out_of_scope · SwitzerlandNA
out_of_scope · SwitzerlandNA
NCT02342366Characterization of the Prosocial and Prosexual Effects of GHB
autism · SwitzerlandNA
autism · SwitzerlandNA
NCT02353949Investigating the Clinical Consequences of Flutemetamol-PET-scanning
alzheimers · SwitzerlandPHASE3
alzheimers · SwitzerlandPHASE3
NCT04736017Auditory Slow Wave Enhancement in Parkinson Disease and Mild Cognitive Impairment
parkinsons · SwitzerlandNA
parkinsons · SwitzerlandNA
NCT05664464Glutamate Inhibitors in Glioblastoma
epilepsy · SwitzerlandPHASE1, PHASE2
epilepsy · SwitzerlandPHASE1, PHASE2
NCT05402488Exploring the Recovery Function of Sleep in Neurodegeneration
parkinsons · SwitzerlandNA
parkinsons · SwitzerlandNA
NCT02557984Dopamine and Opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward Impulsivity
substance_use · SwitzerlandNA
substance_use · SwitzerlandNA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →